View Future GrowthMorpho 過去の業績過去 基準チェック /06Morphoは47.4%の年平均成長率で業績を伸ばしているが、Software業界はgrowingで12.8%毎年増加している。売上は成長しており、年平均15.9%の割合である。主要情報47.42%収益成長率46.71%EPS成長率Software 業界の成長12.13%収益成長率15.93%株主資本利益率-10.12%ネット・マージン-10.50%次回の業績アップデート12 Jun 2026最近の業績更新Reported Earnings • Mar 14First quarter 2026 earnings released: JP¥71.21 loss per share (vs JP¥23.35 loss in 1Q 2025)First quarter 2026 results: JP¥71.21 loss per share (further deteriorated from JP¥23.35 loss in 1Q 2025). Revenue: JP¥474.0m (down 32% from 1Q 2025). Net loss: JP¥374.0m (loss widened 207% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.お知らせ • Jan 22+ 3 more updatesMorpho, Inc. to Report Q3, 2026 Results on Sep 11, 2026Morpho, Inc. announced that they will report Q3, 2026 results on Sep 11, 2026Reported Earnings • Dec 16Full year 2025 earnings released: JP¥14.69 loss per share (vs JP¥58.50 profit in FY 2024)Full year 2025 results: JP¥14.69 loss per share (down from JP¥58.50 profit in FY 2024). Revenue: JP¥3.36b (up 1.8% from FY 2024). Net loss: JP¥77.0m (down 126% from profit in FY 2024). Over the last 3 years on average, earnings per share has increased by 91% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.Reported Earnings • Sep 15Third quarter 2025 earnings released: JP¥3.43 loss per share (vs JP¥8.19 profit in 3Q 2024)Third quarter 2025 results: JP¥3.43 loss per share (down from JP¥8.19 profit in 3Q 2024). Revenue: JP¥802.0m (down 1.2% from 3Q 2024). Net loss: JP¥18.0m (down 143% from profit in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.Reported Earnings • Jun 15Second quarter 2025 earnings released: JP¥13.36 loss per share (vs JP¥39.76 profit in 2Q 2024)Second quarter 2025 results: JP¥13.36 loss per share (down from JP¥39.76 profit in 2Q 2024). Revenue: JP¥832.0m (down 6.1% from 2Q 2024). Net loss: JP¥70.0m (down 134% from profit in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 92% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Reported Earnings • Mar 15First quarter 2025 earnings released: JP¥23.35 loss per share (vs JP¥16.77 loss in 1Q 2024)First quarter 2025 results: JP¥23.35 loss per share (further deteriorated from JP¥16.77 loss in 1Q 2024). Revenue: JP¥699.0m (up 6.7% from 1Q 2024). Net loss: JP¥122.0m (loss widened 42% from 1Q 2024). Over the last 3 years on average, earnings per share has increased by 86% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.すべての更新を表示Recent updatesお知らせ • Mar 31Morpho, Inc. (TSE:3653) announces an Equity Buyback for 140,000 shares, representing 2.67% for ¥110 million.Morpho, Inc. (TSE:3653) announces a share repurchase program. Under the program, the company will repurchase up to 140,000 shares, representing 2.67% of its issued share capital (excluding treasury stock), at ¥613 per share, for ¥110 million. The purpose of the program is to enhance capital efficiency and aim for the sustainable improvement of corporate value.New Risk • Mar 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.8% average weekly change). Market cap is less than US$100m (JP¥3.58b market cap, or US$22.5m).Reported Earnings • Mar 14First quarter 2026 earnings released: JP¥71.21 loss per share (vs JP¥23.35 loss in 1Q 2025)First quarter 2026 results: JP¥71.21 loss per share (further deteriorated from JP¥23.35 loss in 1Q 2025). Revenue: JP¥474.0m (down 32% from 1Q 2025). Net loss: JP¥374.0m (loss widened 207% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.お知らせ • Jan 22+ 3 more updatesMorpho, Inc. to Report Q3, 2026 Results on Sep 11, 2026Morpho, Inc. announced that they will report Q3, 2026 results on Sep 11, 2026Reported Earnings • Dec 16Full year 2025 earnings released: JP¥14.69 loss per share (vs JP¥58.50 profit in FY 2024)Full year 2025 results: JP¥14.69 loss per share (down from JP¥58.50 profit in FY 2024). Revenue: JP¥3.36b (up 1.8% from FY 2024). Net loss: JP¥77.0m (down 126% from profit in FY 2024). Over the last 3 years on average, earnings per share has increased by 91% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.お知らせ • Dec 12Morpho, Inc., Annual General Meeting, Jan 29, 2026Morpho, Inc., Annual General Meeting, Jan 29, 2026.New Risk • Sep 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (5.0% average weekly change). Market cap is less than US$100m (JP¥5.75b market cap, or US$39.1m).Reported Earnings • Sep 15Third quarter 2025 earnings released: JP¥3.43 loss per share (vs JP¥8.19 profit in 3Q 2024)Third quarter 2025 results: JP¥3.43 loss per share (down from JP¥8.19 profit in 3Q 2024). Revenue: JP¥802.0m (down 1.2% from 3Q 2024). Net loss: JP¥18.0m (down 143% from profit in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.Reported Earnings • Jun 15Second quarter 2025 earnings released: JP¥13.36 loss per share (vs JP¥39.76 profit in 2Q 2024)Second quarter 2025 results: JP¥13.36 loss per share (down from JP¥39.76 profit in 2Q 2024). Revenue: JP¥832.0m (down 6.1% from 2Q 2024). Net loss: JP¥70.0m (down 134% from profit in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 92% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.分析記事 • Apr 07Morpho, Inc. (TSE:3653) Stock's 36% Dive Might Signal An Opportunity But It Requires Some ScrutinyMorpho, Inc. ( TSE:3653 ) shareholders that were waiting for something to happen have been dealt a blow with a 36...Valuation Update With 7 Day Price Move • Apr 07Investor sentiment deteriorates as stock falls 26%After last week's 26% share price decline to JP¥872, the stock trades at a trailing P/E ratio of 17.2x. Average trailing P/E is 18x in the Software industry in Japan. Total loss to shareholders of 8.4% over the past three years.Reported Earnings • Mar 15First quarter 2025 earnings released: JP¥23.35 loss per share (vs JP¥16.77 loss in 1Q 2024)First quarter 2025 results: JP¥23.35 loss per share (further deteriorated from JP¥16.77 loss in 1Q 2024). Revenue: JP¥699.0m (up 6.7% from 1Q 2024). Net loss: JP¥122.0m (loss widened 42% from 1Q 2024). Over the last 3 years on average, earnings per share has increased by 86% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.Reported Earnings • Feb 06Full year 2024 earnings released: EPS: JP¥58.50 (vs JP¥58.49 loss in FY 2023)Full year 2024 results: EPS: JP¥58.50 (up from JP¥58.49 loss in FY 2023). Revenue: JP¥3.30b (up 39% from FY 2023). Net income: JP¥301.0m (up JP¥601.0m from FY 2023). Profit margin: 9.1% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.お知らせ • Jan 03+ 3 more updatesMorpho, Inc. to Report Fiscal Year 2025 Results on Dec 12, 2025Morpho, Inc. announced that they will report fiscal year 2025 results on Dec 12, 2025分析記事 • Dec 21We Think That There Are Issues Underlying Morpho's (TSE:3653) EarningsDespite announcing strong earnings, Morpho, Inc.'s ( TSE:3653 ) stock was sluggish. Our analysis uncovered some...Valuation Update With 7 Day Price Move • Dec 20Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to JP¥1,362, the stock trades at a trailing P/E ratio of 23.6x. Average trailing P/E is 22x in the Software industry in Japan. Total returns to shareholders of 22% over the past three years.Reported Earnings • Dec 16Full year 2024 earnings released: EPS: JP¥58.50 (vs JP¥58.49 loss in FY 2023)Full year 2024 results: EPS: JP¥58.50 (up from JP¥58.49 loss in FY 2023). Revenue: JP¥3.30b (up 39% from FY 2023). Net income: JP¥301.0m (up JP¥601.0m from FY 2023). Profit margin: 9.1% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.お知らせ • Dec 13Morpho, Inc., Annual General Meeting, Jan 30, 2025Morpho, Inc., Annual General Meeting, Jan 30, 2025.分析記事 • Sep 18Here's What's Concerning About Morpho's (TSE:3653) Returns On CapitalWhen researching a stock for investment, what can tell us that the company is in decline? A business that's potentially...New Risk • Sep 17New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Market cap is less than US$100m (JP¥8.22b market cap, or US$58.4m).分析記事 • Aug 05Investors Give Morpho, Inc. (TSE:3653) Shares A 28% HidingMorpho, Inc. ( TSE:3653 ) shareholders that were waiting for something to happen have been dealt a blow with a 28...Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 27%After last week's 27% share price decline to JP¥1,307, the stock trades at a trailing P/E ratio of 38.3x. Average trailing P/E is 20x in the Software industry in Japan. Total returns to shareholders of 2.3% over the past three years.分析記事 • Jun 21Impressive Earnings May Not Tell The Whole Story For Morpho (TSE:3653)Morpho, Inc. ( TSE:3653 ) just reported some strong earnings, and the market reacted accordingly with a healthy uplift...New Risk • Jun 17New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 8.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.9% average weekly change). Earnings have declined by 25% per year over the past 5 years. Minor Risk Market cap is less than US$100m (JP¥9.89b market cap, or US$62.8m).Reported Earnings • Jun 17Second quarter 2024 earnings released: EPS: JP¥39.76 (vs JP¥22.23 loss in 2Q 2023)Second quarter 2024 results: EPS: JP¥39.76 (up from JP¥22.23 loss in 2Q 2023). Revenue: JP¥886.0m (up 62% from 2Q 2023). Net income: JP¥204.0m (up JP¥318.0m from 2Q 2023). Profit margin: 23% (up from net loss in 2Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.分析記事 • May 08We're Not Very Worried About Morpho's (TSE:3653) Cash Burn RateJust because a business does not make any money, does not mean that the stock will go down. For example, biotech and...お知らせ • Apr 03Morpho, Inc. to Report Fiscal Year 2024 Results on Dec 13, 2024Morpho, Inc. announced that they will report fiscal year 2024 results on Dec 13, 2024Reported Earnings • Mar 17First quarter 2024 earnings released: JP¥16.77 loss per share (vs JP¥47.38 loss in 1Q 2023)First quarter 2024 results: JP¥16.77 loss per share (improved from JP¥47.38 loss in 1Q 2023). Revenue: JP¥655.0m (up 46% from 1Q 2023). Net loss: JP¥86.0m (loss narrowed 65% from 1Q 2023). Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.分析記事 • Feb 28Investor Optimism Abounds Morpho, Inc. (TSE:3653) But Growth Is LackingWhen close to half the companies in the Software industry in Japan have price-to-sales ratios (or "P/S") below 2.2x...Reported Earnings • Feb 03Full year 2023 earnings released: JP¥58.49 loss per share (vs JP¥130 loss in FY 2022)Full year 2023 results: JP¥58.49 loss per share (improved from JP¥130 loss in FY 2022). Revenue: JP¥2.38b (up 19% from FY 2022). Net loss: JP¥300.0m (loss narrowed 55% from FY 2022). Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.お知らせ • Jan 25+ 2 more updatesMorpho, Inc. to Report Q3, 2024 Results on Sep 13, 2024Morpho, Inc. announced that they will report Q3, 2024 results on Sep 13, 2024お知らせ • Dec 17Morpho, Inc., Annual General Meeting, Jan 30, 2024Morpho, Inc., Annual General Meeting, Jan 30, 2024.Reported Earnings • Dec 16Full year 2023 earnings released: JP¥58.49 loss per share (vs JP¥130 loss in FY 2022)Full year 2023 results: JP¥58.49 loss per share (improved from JP¥130 loss in FY 2022). Revenue: JP¥2.38b (up 19% from FY 2022). Net loss: JP¥300.0m (loss narrowed 55% from FY 2022). Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.New Risk • Nov 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 52% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (5.5% average weekly change). Market cap is less than US$100m (JP¥6.07b market cap, or US$40.3m).Reported Earnings • Sep 11Third quarter 2023 earnings released: JP¥15.60 loss per share (vs JP¥34.51 loss in 3Q 2022)Third quarter 2023 results: JP¥15.60 loss per share (improved from JP¥34.51 loss in 3Q 2022). Revenue: JP¥522.0m (up 4.8% from 3Q 2022). Net loss: JP¥80.0m (loss narrowed 55% from 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has fallen by 16% per year, which means it is performing significantly worse than earnings.Reported Earnings • Jun 12Second quarter 2023 earnings released: JP¥22.23 loss per share (vs JP¥15.99 loss in 2Q 2022)Second quarter 2023 results: JP¥22.23 loss per share (further deteriorated from JP¥15.99 loss in 2Q 2022). Revenue: JP¥547.0m (up 4.0% from 2Q 2022). Net loss: JP¥114.0m (loss widened 39% from 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.Reported Earnings • Mar 11First quarter 2023 earnings released: JP¥47.38 loss per share (vs JP¥42.54 loss in 1Q 2022)First quarter 2023 results: JP¥47.38 loss per share (further deteriorated from JP¥42.54 loss in 1Q 2022). Revenue: JP¥448.0m (up 17% from 1Q 2022). Net loss: JP¥243.0m (loss widened 11% from 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.お知らせ • Feb 09Morpho, Inc.’s SoftNeuro Enables 19x Faster Inference of 3D Simulation on FugakuMorpho, Inc. has provided deep learning inference engine SoftNeuro to a project promoted by the University of Tokyo, Tohoku University, and Kobe University to accelerate high-resolution galaxy formation simulations using deep learning on the supercomputer Fugaku. The result is approx. 19.2 times faster inference time and approx. 93% reduction in power consumption. About Conditions and Measured Values: SoftNeuro is used for 3D-Unet inference on Fugaku. Comparison of inference speed using TensorFlow (available as standard on Fugaku) and using SoftNeuro optimized for Fugaku. Each Fugaku uses 1 node (48 cores). Morpho will support further acceleration of 3D simulations (galaxy formation simulations) using deep learning on Fugaku through the project and collaboration. In addition, Morpho will continue to further improve the convenience and technical capabilities of “SoftNeuro” and develop technology on a global level to realize a fruitful culture through the provision of various services and solutions.Reported Earnings • Feb 02Full year 2022 earnings released: JP¥130 loss per share (vs JP¥147 loss in FY 2021)Full year 2022 results: JP¥130 loss per share (improved from JP¥147 loss in FY 2021). Revenue: JP¥2.00b (up 15% from FY 2021). Net loss: JP¥668.0m (loss narrowed 16% from FY 2021). Over the last 3 years on average, earnings per share has fallen by 58% per year but the company’s share price has only fallen by 28% per year, which means it has not declined as severely as earnings.Reported Earnings • Dec 12Full year 2022 earnings released: JP¥130 loss per share (vs JP¥147 loss in FY 2021)Full year 2022 results: JP¥130 loss per share (improved from JP¥147 loss in FY 2021). Revenue: JP¥2.00b (up 15% from FY 2021). Net loss: JP¥668.0m (loss narrowed 16% from FY 2021). Over the last 3 years on average, earnings per share has fallen by 58% per year but the company’s share price has only fallen by 33% per year, which means it has not declined as severely as earnings.Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Senior Director Kiyohito Nagata was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Oct 30+ 3 more updatesMorpho, Inc. to Report Q2, 2023 Results on Jun 09, 2023Morpho, Inc. announced that they will report Q2, 2023 results on Jun 09, 2023Reported Earnings • Sep 11Third quarter 2022 earnings released: JP¥34.51 loss per share (vs JP¥43.42 loss in 3Q 2021)Third quarter 2022 results: JP¥34.51 loss per share (improved from JP¥43.42 loss in 3Q 2021). Revenue: JP¥498.0m (up 21% from 3Q 2021). Net loss: JP¥177.0m (loss narrowed 25% from 3Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 46 percentage points per year, which is a significant difference in performance.Reported Earnings • Jun 13Second quarter 2022 earnings released: JP¥15.99 loss per share (vs JP¥21.26 loss in 2Q 2021)Second quarter 2022 results: JP¥15.99 loss per share (up from JP¥21.26 loss in 2Q 2021). Revenue: JP¥526.0m (up 9.6% from 2Q 2021). Net loss: JP¥82.0m (loss narrowed 29% from 2Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance.Board Change • Apr 30Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Senior Director Kiyohito Nagata was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Mar 29Morpho, Inc. to Report Fiscal Year 2022 Results on Dec 09, 2022Morpho, Inc. announced that they will report fiscal year 2022 results on Dec 09, 2022Reported Earnings • Mar 13First quarter 2022 earnings: Revenues and EPS in line with analyst expectationsFirst quarter 2022 results: JP¥42.54 loss per share (up from JP¥45.94 loss in 1Q 2021). Revenue: JP¥382.0m (up 14% from 1Q 2021). Net loss: JP¥220.0m (loss narrowed 11% from 1Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 78 percentage points per year, which is a significant difference in performance.Reported Earnings • Feb 04Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: JP¥147 loss per share (down from JP¥121 loss in FY 2020). Revenue: JP¥1.73b (down 17% from FY 2020). Net loss: JP¥793.0m (loss widened 22% from FY 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 84 percentage points per year, which is a significant difference in performance.Reported Earnings • Dec 14Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: JP¥147 loss per share (down from JP¥121 loss in FY 2020). Revenue: JP¥1.73b (down 17% from FY 2020). Net loss: JP¥793.0m (loss widened 22% from FY 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 90 percentage points per year, which is a significant difference in performance.お知らせ • Sep 11Morpho, Inc. (TSE:3653) announces an Equity Buyback for 300,000 shares, representing 5.54% for ¥360 million.Morpho, Inc. (TSE:3653) announces a share repurchase program. Under the program, the company will repurchase up to 500,000 shares, representing 5.54% of its issued share capital (excluding treasury stock), at ¥1,200 per share, for ¥360 million. The purpose of the program is to utilize the incentive plan to promote the growth of the group and to carry out a flexible capital policy according to the business environment The program will run until March 16, 2022. As of August 31, 2021, the company had 5,414,000 shares in issue (excluding treasury stock) and 1,817 shares in treasury.Reported Earnings • Jun 14Second quarter 2021 earnings released: JP¥21.26 loss per share (vs JP¥10.77 profit in 2Q 2020)The company reported a poor second quarter result with weaker earnings, revenues and control over costs. Second quarter 2021 results: Revenue: JP¥480.0m (down 24% from 2Q 2020). Net loss: JP¥115.0m (down 298% from profit in 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 75 percentage points per year, which is a significant difference in performance.Reported Earnings • Mar 14First quarter 2021 earnings released: JP¥45.94 loss per share (vs JP¥9.10 loss in 1Q 2020)The company reported a poor first quarter result with increased losses, weaker revenues and weaker control over costs. First quarter 2021 results: Revenue: JP¥335.0m (down 30% from 1Q 2020). Net loss: JP¥248.0m (loss widened 406% from 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 86% per year but the company’s share price has only fallen by 26% per year, which means it has not declined as severely as earnings.お知らせ • Mar 10Morpho, Inc. to Report Fiscal Year 2021 Results on Dec 10, 2021Morpho, Inc. announced that they will report fiscal year 2021 results on Dec 10, 2021お知らせ • Mar 09+ 1 more updateMorpho, Inc. to Report Q2, 2021 Results on Jun 11, 2021Morpho, Inc. announced that they will report Q2, 2021 results on Jun 11, 2021Reported Earnings • Feb 02Full year 2020 earnings released: JP¥121 loss per share (vs JP¥62.97 profit in FY 2019)The company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2020 results: Revenue: JP¥2.07b (down 21% from FY 2019). Net loss: JP¥652.0m (down 292% from profit in FY 2019). Over the last 3 years on average, earnings per share has fallen by 67% per year but the company’s share price has only fallen by 29% per year, which means it has not declined as severely as earnings.お知らせ • Jan 12Morpho, Inc. to Report Q1, 2021 Results on Mar 12, 2021Morpho, Inc. announced that they will report Q1, 2021 results on Mar 12, 2021Is New 90 Day High Low • Dec 22New 90-day low: JP¥1,371The company is down 23% from its price of JP¥1,770 on 23 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is up 2.0% over the same period.Reported Earnings • Dec 15Full year 2020 earnings released: JP¥121 loss per shareThe company reported a poor full year result with weaker earnings, revenues and control over expenses. Full year 2020 results: Revenue: JP¥2.07b (down 21% from FY 2019). Net loss: JP¥652.0m (down 292% from profit in FY 2019). Over the last 3 years on average, earnings per share has fallen by 67% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings.お知らせ • Dec 13Morpho, Inc., Annual General Meeting, Jan 29, 2021Morpho, Inc., Annual General Meeting, Jan 29, 2021.お知らせ • Sep 21Morpho, Inc.(TSE:3653) dropped from S&P Global BMI IndexMorpho, Inc.(TSE:3653) dropped from S&P Global BMI Indexお知らせ • Jul 19Morpho, Inc. to Report Q3, 2020 Results on Sep 11, 2020Morpho, Inc. announced that they will report Q3, 2020 results on Sep 11, 2020収支内訳Morpho の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史TSE:3653 収益、費用、利益 ( )JPY Millions日付収益収益G+A経費研究開発費31 Jan 263,134-3291,28454531 Oct 253,359-771,25254531 Jul 253,280-691,37837730 Apr 253,290-91,35537731 Jan 253,3442651,31437731 Oct 243,3003011,26537731 Jul 243,2192971,21545730 Apr 242,9291751,22145731 Jan 242,590-1431,19045731 Oct 232,383-3001,14445731 Jul 232,108-62698747930 Apr 232,084-7231,00647931 Jan 232,063-6911,01647931 Oct 221,997-6681,06147931 Jul 221,908-6741,09055330 Apr 221,823-7321,13555331 Jan 221,777-7651,19455331 Oct 211,730-7931,19555331 Jul 211,748-9291,24549030 Apr 211,779-1,0241,17149031 Jan 211,931-8511,10649031 Oct 202,073-6521,08949031 Jul 202,239-2561,16240130 Apr 202,4641611,13440131 Jan 202,5112771,11940131 Oct 192,6083391,07040131 Jul 192,6925211,02935330 Apr 192,61154495435331 Jan 192,46543392435331 Oct 182,41746591635331 Jul 182,26936994236730 Apr 182,21635994536731 Jan 182,38052090936731 Oct 172,35763082236731 Jul 172,32161489622130 Apr 172,30362882922131 Jan 172,07945479222131 Oct 162,14350774422131 Jul 162,03254374216130 Apr 162,03551371116131 Jan 162,05563764916131 Oct 152,03760463516131 Jul 151,983607631189質の高い収益: 3653は現在利益が出ていません。利益率の向上: 3653は現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: 3653は利益を出していないが、過去 5 年間で年間47.4%の割合で損失を削減してきた。成長の加速: 3653の過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: 3653は利益が出ていないため、過去 1 年間の収益成長をSoftware業界 ( 18.2% ) と比較することは困難です。株主資本利益率高いROE: 3653は現在利益が出ていないため、自己資本利益率 ( -10.12% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YSoftware 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/14 13:35終値2026/05/14 00:00収益2026/01/31年間収益2025/10/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Morpho, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Daisaku MasunoNomura Securities Co. Ltd.
Reported Earnings • Mar 14First quarter 2026 earnings released: JP¥71.21 loss per share (vs JP¥23.35 loss in 1Q 2025)First quarter 2026 results: JP¥71.21 loss per share (further deteriorated from JP¥23.35 loss in 1Q 2025). Revenue: JP¥474.0m (down 32% from 1Q 2025). Net loss: JP¥374.0m (loss widened 207% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
お知らせ • Jan 22+ 3 more updatesMorpho, Inc. to Report Q3, 2026 Results on Sep 11, 2026Morpho, Inc. announced that they will report Q3, 2026 results on Sep 11, 2026
Reported Earnings • Dec 16Full year 2025 earnings released: JP¥14.69 loss per share (vs JP¥58.50 profit in FY 2024)Full year 2025 results: JP¥14.69 loss per share (down from JP¥58.50 profit in FY 2024). Revenue: JP¥3.36b (up 1.8% from FY 2024). Net loss: JP¥77.0m (down 126% from profit in FY 2024). Over the last 3 years on average, earnings per share has increased by 91% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
Reported Earnings • Sep 15Third quarter 2025 earnings released: JP¥3.43 loss per share (vs JP¥8.19 profit in 3Q 2024)Third quarter 2025 results: JP¥3.43 loss per share (down from JP¥8.19 profit in 3Q 2024). Revenue: JP¥802.0m (down 1.2% from 3Q 2024). Net loss: JP¥18.0m (down 143% from profit in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Jun 15Second quarter 2025 earnings released: JP¥13.36 loss per share (vs JP¥39.76 profit in 2Q 2024)Second quarter 2025 results: JP¥13.36 loss per share (down from JP¥39.76 profit in 2Q 2024). Revenue: JP¥832.0m (down 6.1% from 2Q 2024). Net loss: JP¥70.0m (down 134% from profit in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 92% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Mar 15First quarter 2025 earnings released: JP¥23.35 loss per share (vs JP¥16.77 loss in 1Q 2024)First quarter 2025 results: JP¥23.35 loss per share (further deteriorated from JP¥16.77 loss in 1Q 2024). Revenue: JP¥699.0m (up 6.7% from 1Q 2024). Net loss: JP¥122.0m (loss widened 42% from 1Q 2024). Over the last 3 years on average, earnings per share has increased by 86% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.
お知らせ • Mar 31Morpho, Inc. (TSE:3653) announces an Equity Buyback for 140,000 shares, representing 2.67% for ¥110 million.Morpho, Inc. (TSE:3653) announces a share repurchase program. Under the program, the company will repurchase up to 140,000 shares, representing 2.67% of its issued share capital (excluding treasury stock), at ¥613 per share, for ¥110 million. The purpose of the program is to enhance capital efficiency and aim for the sustainable improvement of corporate value.
New Risk • Mar 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.8% average weekly change). Market cap is less than US$100m (JP¥3.58b market cap, or US$22.5m).
Reported Earnings • Mar 14First quarter 2026 earnings released: JP¥71.21 loss per share (vs JP¥23.35 loss in 1Q 2025)First quarter 2026 results: JP¥71.21 loss per share (further deteriorated from JP¥23.35 loss in 1Q 2025). Revenue: JP¥474.0m (down 32% from 1Q 2025). Net loss: JP¥374.0m (loss widened 207% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
お知らせ • Jan 22+ 3 more updatesMorpho, Inc. to Report Q3, 2026 Results on Sep 11, 2026Morpho, Inc. announced that they will report Q3, 2026 results on Sep 11, 2026
Reported Earnings • Dec 16Full year 2025 earnings released: JP¥14.69 loss per share (vs JP¥58.50 profit in FY 2024)Full year 2025 results: JP¥14.69 loss per share (down from JP¥58.50 profit in FY 2024). Revenue: JP¥3.36b (up 1.8% from FY 2024). Net loss: JP¥77.0m (down 126% from profit in FY 2024). Over the last 3 years on average, earnings per share has increased by 91% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
お知らせ • Dec 12Morpho, Inc., Annual General Meeting, Jan 29, 2026Morpho, Inc., Annual General Meeting, Jan 29, 2026.
New Risk • Sep 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (5.0% average weekly change). Market cap is less than US$100m (JP¥5.75b market cap, or US$39.1m).
Reported Earnings • Sep 15Third quarter 2025 earnings released: JP¥3.43 loss per share (vs JP¥8.19 profit in 3Q 2024)Third quarter 2025 results: JP¥3.43 loss per share (down from JP¥8.19 profit in 3Q 2024). Revenue: JP¥802.0m (down 1.2% from 3Q 2024). Net loss: JP¥18.0m (down 143% from profit in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Jun 15Second quarter 2025 earnings released: JP¥13.36 loss per share (vs JP¥39.76 profit in 2Q 2024)Second quarter 2025 results: JP¥13.36 loss per share (down from JP¥39.76 profit in 2Q 2024). Revenue: JP¥832.0m (down 6.1% from 2Q 2024). Net loss: JP¥70.0m (down 134% from profit in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 92% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
分析記事 • Apr 07Morpho, Inc. (TSE:3653) Stock's 36% Dive Might Signal An Opportunity But It Requires Some ScrutinyMorpho, Inc. ( TSE:3653 ) shareholders that were waiting for something to happen have been dealt a blow with a 36...
Valuation Update With 7 Day Price Move • Apr 07Investor sentiment deteriorates as stock falls 26%After last week's 26% share price decline to JP¥872, the stock trades at a trailing P/E ratio of 17.2x. Average trailing P/E is 18x in the Software industry in Japan. Total loss to shareholders of 8.4% over the past three years.
Reported Earnings • Mar 15First quarter 2025 earnings released: JP¥23.35 loss per share (vs JP¥16.77 loss in 1Q 2024)First quarter 2025 results: JP¥23.35 loss per share (further deteriorated from JP¥16.77 loss in 1Q 2024). Revenue: JP¥699.0m (up 6.7% from 1Q 2024). Net loss: JP¥122.0m (loss widened 42% from 1Q 2024). Over the last 3 years on average, earnings per share has increased by 86% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Feb 06Full year 2024 earnings released: EPS: JP¥58.50 (vs JP¥58.49 loss in FY 2023)Full year 2024 results: EPS: JP¥58.50 (up from JP¥58.49 loss in FY 2023). Revenue: JP¥3.30b (up 39% from FY 2023). Net income: JP¥301.0m (up JP¥601.0m from FY 2023). Profit margin: 9.1% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.
お知らせ • Jan 03+ 3 more updatesMorpho, Inc. to Report Fiscal Year 2025 Results on Dec 12, 2025Morpho, Inc. announced that they will report fiscal year 2025 results on Dec 12, 2025
分析記事 • Dec 21We Think That There Are Issues Underlying Morpho's (TSE:3653) EarningsDespite announcing strong earnings, Morpho, Inc.'s ( TSE:3653 ) stock was sluggish. Our analysis uncovered some...
Valuation Update With 7 Day Price Move • Dec 20Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to JP¥1,362, the stock trades at a trailing P/E ratio of 23.6x. Average trailing P/E is 22x in the Software industry in Japan. Total returns to shareholders of 22% over the past three years.
Reported Earnings • Dec 16Full year 2024 earnings released: EPS: JP¥58.50 (vs JP¥58.49 loss in FY 2023)Full year 2024 results: EPS: JP¥58.50 (up from JP¥58.49 loss in FY 2023). Revenue: JP¥3.30b (up 39% from FY 2023). Net income: JP¥301.0m (up JP¥601.0m from FY 2023). Profit margin: 9.1% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.
お知らせ • Dec 13Morpho, Inc., Annual General Meeting, Jan 30, 2025Morpho, Inc., Annual General Meeting, Jan 30, 2025.
分析記事 • Sep 18Here's What's Concerning About Morpho's (TSE:3653) Returns On CapitalWhen researching a stock for investment, what can tell us that the company is in decline? A business that's potentially...
New Risk • Sep 17New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Market cap is less than US$100m (JP¥8.22b market cap, or US$58.4m).
分析記事 • Aug 05Investors Give Morpho, Inc. (TSE:3653) Shares A 28% HidingMorpho, Inc. ( TSE:3653 ) shareholders that were waiting for something to happen have been dealt a blow with a 28...
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 27%After last week's 27% share price decline to JP¥1,307, the stock trades at a trailing P/E ratio of 38.3x. Average trailing P/E is 20x in the Software industry in Japan. Total returns to shareholders of 2.3% over the past three years.
分析記事 • Jun 21Impressive Earnings May Not Tell The Whole Story For Morpho (TSE:3653)Morpho, Inc. ( TSE:3653 ) just reported some strong earnings, and the market reacted accordingly with a healthy uplift...
New Risk • Jun 17New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 8.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.9% average weekly change). Earnings have declined by 25% per year over the past 5 years. Minor Risk Market cap is less than US$100m (JP¥9.89b market cap, or US$62.8m).
Reported Earnings • Jun 17Second quarter 2024 earnings released: EPS: JP¥39.76 (vs JP¥22.23 loss in 2Q 2023)Second quarter 2024 results: EPS: JP¥39.76 (up from JP¥22.23 loss in 2Q 2023). Revenue: JP¥886.0m (up 62% from 2Q 2023). Net income: JP¥204.0m (up JP¥318.0m from 2Q 2023). Profit margin: 23% (up from net loss in 2Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.
分析記事 • May 08We're Not Very Worried About Morpho's (TSE:3653) Cash Burn RateJust because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
お知らせ • Apr 03Morpho, Inc. to Report Fiscal Year 2024 Results on Dec 13, 2024Morpho, Inc. announced that they will report fiscal year 2024 results on Dec 13, 2024
Reported Earnings • Mar 17First quarter 2024 earnings released: JP¥16.77 loss per share (vs JP¥47.38 loss in 1Q 2023)First quarter 2024 results: JP¥16.77 loss per share (improved from JP¥47.38 loss in 1Q 2023). Revenue: JP¥655.0m (up 46% from 1Q 2023). Net loss: JP¥86.0m (loss narrowed 65% from 1Q 2023). Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.
分析記事 • Feb 28Investor Optimism Abounds Morpho, Inc. (TSE:3653) But Growth Is LackingWhen close to half the companies in the Software industry in Japan have price-to-sales ratios (or "P/S") below 2.2x...
Reported Earnings • Feb 03Full year 2023 earnings released: JP¥58.49 loss per share (vs JP¥130 loss in FY 2022)Full year 2023 results: JP¥58.49 loss per share (improved from JP¥130 loss in FY 2022). Revenue: JP¥2.38b (up 19% from FY 2022). Net loss: JP¥300.0m (loss narrowed 55% from FY 2022). Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
お知らせ • Jan 25+ 2 more updatesMorpho, Inc. to Report Q3, 2024 Results on Sep 13, 2024Morpho, Inc. announced that they will report Q3, 2024 results on Sep 13, 2024
お知らせ • Dec 17Morpho, Inc., Annual General Meeting, Jan 30, 2024Morpho, Inc., Annual General Meeting, Jan 30, 2024.
Reported Earnings • Dec 16Full year 2023 earnings released: JP¥58.49 loss per share (vs JP¥130 loss in FY 2022)Full year 2023 results: JP¥58.49 loss per share (improved from JP¥130 loss in FY 2022). Revenue: JP¥2.38b (up 19% from FY 2022). Net loss: JP¥300.0m (loss narrowed 55% from FY 2022). Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
New Risk • Nov 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 52% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (5.5% average weekly change). Market cap is less than US$100m (JP¥6.07b market cap, or US$40.3m).
Reported Earnings • Sep 11Third quarter 2023 earnings released: JP¥15.60 loss per share (vs JP¥34.51 loss in 3Q 2022)Third quarter 2023 results: JP¥15.60 loss per share (improved from JP¥34.51 loss in 3Q 2022). Revenue: JP¥522.0m (up 4.8% from 3Q 2022). Net loss: JP¥80.0m (loss narrowed 55% from 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has fallen by 16% per year, which means it is performing significantly worse than earnings.
Reported Earnings • Jun 12Second quarter 2023 earnings released: JP¥22.23 loss per share (vs JP¥15.99 loss in 2Q 2022)Second quarter 2023 results: JP¥22.23 loss per share (further deteriorated from JP¥15.99 loss in 2Q 2022). Revenue: JP¥547.0m (up 4.0% from 2Q 2022). Net loss: JP¥114.0m (loss widened 39% from 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
Reported Earnings • Mar 11First quarter 2023 earnings released: JP¥47.38 loss per share (vs JP¥42.54 loss in 1Q 2022)First quarter 2023 results: JP¥47.38 loss per share (further deteriorated from JP¥42.54 loss in 1Q 2022). Revenue: JP¥448.0m (up 17% from 1Q 2022). Net loss: JP¥243.0m (loss widened 11% from 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
お知らせ • Feb 09Morpho, Inc.’s SoftNeuro Enables 19x Faster Inference of 3D Simulation on FugakuMorpho, Inc. has provided deep learning inference engine SoftNeuro to a project promoted by the University of Tokyo, Tohoku University, and Kobe University to accelerate high-resolution galaxy formation simulations using deep learning on the supercomputer Fugaku. The result is approx. 19.2 times faster inference time and approx. 93% reduction in power consumption. About Conditions and Measured Values: SoftNeuro is used for 3D-Unet inference on Fugaku. Comparison of inference speed using TensorFlow (available as standard on Fugaku) and using SoftNeuro optimized for Fugaku. Each Fugaku uses 1 node (48 cores). Morpho will support further acceleration of 3D simulations (galaxy formation simulations) using deep learning on Fugaku through the project and collaboration. In addition, Morpho will continue to further improve the convenience and technical capabilities of “SoftNeuro” and develop technology on a global level to realize a fruitful culture through the provision of various services and solutions.
Reported Earnings • Feb 02Full year 2022 earnings released: JP¥130 loss per share (vs JP¥147 loss in FY 2021)Full year 2022 results: JP¥130 loss per share (improved from JP¥147 loss in FY 2021). Revenue: JP¥2.00b (up 15% from FY 2021). Net loss: JP¥668.0m (loss narrowed 16% from FY 2021). Over the last 3 years on average, earnings per share has fallen by 58% per year but the company’s share price has only fallen by 28% per year, which means it has not declined as severely as earnings.
Reported Earnings • Dec 12Full year 2022 earnings released: JP¥130 loss per share (vs JP¥147 loss in FY 2021)Full year 2022 results: JP¥130 loss per share (improved from JP¥147 loss in FY 2021). Revenue: JP¥2.00b (up 15% from FY 2021). Net loss: JP¥668.0m (loss narrowed 16% from FY 2021). Over the last 3 years on average, earnings per share has fallen by 58% per year but the company’s share price has only fallen by 33% per year, which means it has not declined as severely as earnings.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Senior Director Kiyohito Nagata was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Oct 30+ 3 more updatesMorpho, Inc. to Report Q2, 2023 Results on Jun 09, 2023Morpho, Inc. announced that they will report Q2, 2023 results on Jun 09, 2023
Reported Earnings • Sep 11Third quarter 2022 earnings released: JP¥34.51 loss per share (vs JP¥43.42 loss in 3Q 2021)Third quarter 2022 results: JP¥34.51 loss per share (improved from JP¥43.42 loss in 3Q 2021). Revenue: JP¥498.0m (up 21% from 3Q 2021). Net loss: JP¥177.0m (loss narrowed 25% from 3Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 46 percentage points per year, which is a significant difference in performance.
Reported Earnings • Jun 13Second quarter 2022 earnings released: JP¥15.99 loss per share (vs JP¥21.26 loss in 2Q 2021)Second quarter 2022 results: JP¥15.99 loss per share (up from JP¥21.26 loss in 2Q 2021). Revenue: JP¥526.0m (up 9.6% from 2Q 2021). Net loss: JP¥82.0m (loss narrowed 29% from 2Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance.
Board Change • Apr 30Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Senior Director Kiyohito Nagata was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Mar 29Morpho, Inc. to Report Fiscal Year 2022 Results on Dec 09, 2022Morpho, Inc. announced that they will report fiscal year 2022 results on Dec 09, 2022
Reported Earnings • Mar 13First quarter 2022 earnings: Revenues and EPS in line with analyst expectationsFirst quarter 2022 results: JP¥42.54 loss per share (up from JP¥45.94 loss in 1Q 2021). Revenue: JP¥382.0m (up 14% from 1Q 2021). Net loss: JP¥220.0m (loss narrowed 11% from 1Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 78 percentage points per year, which is a significant difference in performance.
Reported Earnings • Feb 04Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: JP¥147 loss per share (down from JP¥121 loss in FY 2020). Revenue: JP¥1.73b (down 17% from FY 2020). Net loss: JP¥793.0m (loss widened 22% from FY 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 84 percentage points per year, which is a significant difference in performance.
Reported Earnings • Dec 14Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: JP¥147 loss per share (down from JP¥121 loss in FY 2020). Revenue: JP¥1.73b (down 17% from FY 2020). Net loss: JP¥793.0m (loss widened 22% from FY 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 90 percentage points per year, which is a significant difference in performance.
お知らせ • Sep 11Morpho, Inc. (TSE:3653) announces an Equity Buyback for 300,000 shares, representing 5.54% for ¥360 million.Morpho, Inc. (TSE:3653) announces a share repurchase program. Under the program, the company will repurchase up to 500,000 shares, representing 5.54% of its issued share capital (excluding treasury stock), at ¥1,200 per share, for ¥360 million. The purpose of the program is to utilize the incentive plan to promote the growth of the group and to carry out a flexible capital policy according to the business environment The program will run until March 16, 2022. As of August 31, 2021, the company had 5,414,000 shares in issue (excluding treasury stock) and 1,817 shares in treasury.
Reported Earnings • Jun 14Second quarter 2021 earnings released: JP¥21.26 loss per share (vs JP¥10.77 profit in 2Q 2020)The company reported a poor second quarter result with weaker earnings, revenues and control over costs. Second quarter 2021 results: Revenue: JP¥480.0m (down 24% from 2Q 2020). Net loss: JP¥115.0m (down 298% from profit in 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 75 percentage points per year, which is a significant difference in performance.
Reported Earnings • Mar 14First quarter 2021 earnings released: JP¥45.94 loss per share (vs JP¥9.10 loss in 1Q 2020)The company reported a poor first quarter result with increased losses, weaker revenues and weaker control over costs. First quarter 2021 results: Revenue: JP¥335.0m (down 30% from 1Q 2020). Net loss: JP¥248.0m (loss widened 406% from 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 86% per year but the company’s share price has only fallen by 26% per year, which means it has not declined as severely as earnings.
お知らせ • Mar 10Morpho, Inc. to Report Fiscal Year 2021 Results on Dec 10, 2021Morpho, Inc. announced that they will report fiscal year 2021 results on Dec 10, 2021
お知らせ • Mar 09+ 1 more updateMorpho, Inc. to Report Q2, 2021 Results on Jun 11, 2021Morpho, Inc. announced that they will report Q2, 2021 results on Jun 11, 2021
Reported Earnings • Feb 02Full year 2020 earnings released: JP¥121 loss per share (vs JP¥62.97 profit in FY 2019)The company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2020 results: Revenue: JP¥2.07b (down 21% from FY 2019). Net loss: JP¥652.0m (down 292% from profit in FY 2019). Over the last 3 years on average, earnings per share has fallen by 67% per year but the company’s share price has only fallen by 29% per year, which means it has not declined as severely as earnings.
お知らせ • Jan 12Morpho, Inc. to Report Q1, 2021 Results on Mar 12, 2021Morpho, Inc. announced that they will report Q1, 2021 results on Mar 12, 2021
Is New 90 Day High Low • Dec 22New 90-day low: JP¥1,371The company is down 23% from its price of JP¥1,770 on 23 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is up 2.0% over the same period.
Reported Earnings • Dec 15Full year 2020 earnings released: JP¥121 loss per shareThe company reported a poor full year result with weaker earnings, revenues and control over expenses. Full year 2020 results: Revenue: JP¥2.07b (down 21% from FY 2019). Net loss: JP¥652.0m (down 292% from profit in FY 2019). Over the last 3 years on average, earnings per share has fallen by 67% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings.
お知らせ • Dec 13Morpho, Inc., Annual General Meeting, Jan 29, 2021Morpho, Inc., Annual General Meeting, Jan 29, 2021.
お知らせ • Sep 21Morpho, Inc.(TSE:3653) dropped from S&P Global BMI IndexMorpho, Inc.(TSE:3653) dropped from S&P Global BMI Index
お知らせ • Jul 19Morpho, Inc. to Report Q3, 2020 Results on Sep 11, 2020Morpho, Inc. announced that they will report Q3, 2020 results on Sep 11, 2020